Restoring elastin with MicroRNA-29

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 3, 2012, Pages 548-551

  Dong, Xiu Rong ^a   Majesky, Mark W ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

aneurysms; extracellular matrix; gene expression; morphogenesis

Indexed keywords

ELASTIN; FIBRILLIN; FIBULIN 5; MICRORNA; MICRORNA 29; TROPOELASTIN; UNCLASSIFIED DRUG;

BURN; CROSS LINKING; DISEASE ASSOCIATION; ELASTIC FIBER; EMPHYSEMA; EXTRACELLULAR MATRIX; FIBROSIS; HAPLOINSUFFICIENCY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SYSTEMIC SCLEROSIS; WILLIAMS BEUREN SYNDROME;

ARTERIES; BLOOD VESSEL PROSTHESIS; ELASTIN; FIBROBLASTS; HAPLOINSUFFICIENCY; HUMANS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE;

EID: 84857568816     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.242412     Document Type: Review

References (28)

1. Baldock C, Oberhouser AF, Ma L, Lammie D, Siegler V, Mithieux SM, Tu Y, Chow JY, Suleman F, Malfois M, Rogers S, Guo L, Irving TC, Wess TJ, Weiss AS. Shape of tropoelastin, the highly distensible protein that controls human tissue elasticity. Proc Natl Acad Sci USA. 2011; 108:4322-4327.
2. Bashir MM, Indik Z, Yeh H, Omstein-Goldstein N, Rosenbloom JC, Abrams W, Fazio M, Uitto J, Rosenbloom J. Characterization of the complete human elastin gene: delineation of unusual features in the 5-flanking region. J Biol Chem. 1989;264:8887-8891. (Pubitemid 19151613)
3. Davis EC. Stability of elastin in the developing mouse aorta: a quantitative radioautographic study. Histochemistry. 1993;100:17-26. (Pubitemid 23240229)
4. Sherratt MJ. Tissue elasticity and the ageing elastic fibre. Age. 2009;31: 305-325.
5. Rnjak J, Wise SG, Mithieux SM, Weiss AS. Severe burn injuries and the role of elastin in the design of dermal substitutes. Tissue Eng Part B Rev. 2011;17:81-91.
6. Suabe J. Serizawa A, Kajiwara H, Ohkido M, Tsutsumi Y. Degenerative processes of elastic fibers in sun-protected and sun-exposed skin: immunoelectron microscopic observation of elastin, fibrillin-1, amyloid P component, lysosyme and α1-antitrypsin. Pathol Int. 1999;49:391-402. (Pubitemid 29309668)
7. Davis EC, Blattel SA, Mecham RP. Remodeling of elastic fiber components in scleroderma skin. Connect Tissue Res. 1999;40:113-121. (Pubitemid 29298221)
8. Loeys BL, Gerber EE, Rieger-Johnson D, Iqbal S, Whiteman P, McConnell V, Chillakuri CR, Macaya D, Coucke PJ, De Paepe A, Judge DP, Wigley F, Davis EC, Mardon HJ, Handford P, Keene DR, Sakai L, Dietz HC. Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Sci Transl Med. 2010;2:23ra20.
9. Ryan ST, Koteliansky VE, Gotwals PJ, Lindner V. Transforming growth factor-β-dependent events in vascular remodeling following arterial injury. J Vasc Res. 2002;40:37-46.
10. Zhang P, Huang A, Ferruzzi J, Mecham RP, Starcher BC, Tellides G, Humphrey JD, Giordano FJ, Niklason LE, Sessa WC. Inhibition of microRNA-29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels-brief report. Arterioscler Thromb Vasc Biol. 2012;32:756-759.
11. Ramirez F, Dietz HC. Extracellular microfibrils in vertebrate development and disease processes. J Biol Chem. 2009;284:14677-14681.
12. Wagenseil JE, Mecham RP. Vascular extracellular matrix and arterial mechanics. Physiol Rev. 2009;89:957-989.
13. Kagan HM, Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem. 2003;88:660-672. (Pubitemid 36258816)
14. Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB, Eichwald E, Keating MT. Elastin is an essential determinant of arterial morphogenesis. Nature. 1998;393:276-280. (Pubitemid 28261728)
15. Faury G, Pezet M, Knutsen RH, Boyle WA, Heximer SP, McLean SE, Minkes RK, Blumer KJ, Kovacs A, Kelly DP, Li DY, Starcher B, Mecham RP. Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. J Clin Invest. 2003;112:1419-1428. (Pubitemid 38057695)
16. Pober BR, Johnson M, Urban Z. Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome. J Clin Invest. 2008;118: 1606-1615. (Pubitemid 351632362)
17. Urban Z, Zhang J, Davis EC, Maeda GK, Kumar A, Stalker H, Belmont JH, Boyd CD, Wallace MR. Supravalvular aortic stenosis: genetic and molecular dissection of a complex mutation in the elastin gene. Hum Genet. 2001;109:512-520. (Pubitemid 33089310)
18. Urban Z, Riazi S, Seidl TL, Katagira J, Smoot LB, Chitayat D, Boyd CD, Hinek A. Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome. Am J Hum Genet. 2002;71:30-44. (Pubitemid 34734705)
19. Bartel D. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-233.
20. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature. 2011;409:336-342.
21. Ott CE, Grunhagen J, Jager M, Horbelt D, Schwill S, Kallenbach K, Guo G, Manke T, Knauss P, Mundlos S, Robinson PN. MicroRNAs differentially expressed in postnatal aortic development downregulate elastin via 3́UTR and coding-sequence binding sites. PLoS One. 2011;6:e16250.
22. Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods. 2007;4: 721-726. (Pubitemid 47338166)
23. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA. 2008;105:13027-13032.
24. Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, Horrevoets AJ, Vinciguerra M, Rosenthal N, Sciacca S, Pilato M, van Heijningen P, Essers J, Brandes RP, Zeiher AM, Dimmeler S. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res. 2011;109: 1115-1119.
25. Merk DR, Chin JT, Dake BA, Maegdefessel L, Miller MO, Kimura N, Tsao PS, Iosef C, Berry GJ, Mohr FW, Spin JM, Alvira CM, Robbins RC, Fischbein MP. miR-29b participates in early aneurysm development in Marfan Syndrome. Circ Res. 2012;110:312-324.
26. Kwiecinski M, Noetel A, Elfimova N, Trebicka J, Schievenbusch S, Strack I, Molnar L, von Brandenstein M, Tox U, Nischt R, Coutelle O, Dienes HP, Odenthal M. Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction. PLoS One. 2011;6:e24568.
27. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV, Lu J. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol. 2011;45:287-294.
28. Qin W, Chung C, Huang XR, Meng XM, Hui DS, Yu CS, Sung JJ, Lan HY. TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol. 2011;22:1462-1474